WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients. Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday. So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses. “It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.” |
Planning for potential presidential transition underway as Biden administration kicks it off2024 NFL Draft: From Caleb Williams' gorgeous longEmma Roberts has 'best day ever' going to Disneyland 'for the first time' with her son RhodesJ.D. Martinez makes his Mets debut after he was sidelined by back issuesJelly Roll is seen in goodOregon State and Washington State face player exodus amid realignmentOutfielder Tommy Pham returns to major leagues with the MLBMy body is 70% covered by tattoosFEC fines exOregon State and Washington State face player exodus amid realignment